Protocol update and baseline characteristics for the TRIal to slow the Progression of Diabetes (TRIPOD) randomized controlled trial

被引:0
|
作者
Joann Bairavi
Daphne Su-Lyn Gardner
Ester Yeoh
Kwang Wei Tham
Mihir Gandhi
Ngiap Chuan Tan
Phong Ching Lee
Robyn Su May Lim
Thofique Adamjee
Yin Bun Cheung
Yong Mong Bee
Eric Andrew Finkelstein
机构
[1] Duke-NUS Medical School,Health Services & Systems Research
[2] Singapore General Hospital,Department of Endocrinology
[3] Khoo Teck Puat Hospital,Diabetes Centre, Admiralty Medical Centre
[4] Woodlands Health,Endocrinology Services
[5] Duke-NUS Medical School,Centre for Quantitative Medicine
[6] Singapore Clinical Research Institute,Department of Biostatistics
[7] 167 Jalan Bukit Merah,Department of Research, SingHealth Polyclinics
[8] Connection One,Health Promotion Board
[9] 3 Second Hospital Avenue,Department of General Medicine
[10] Khoo Teck Puat Hospital,undefined
来源
Trials | / 24卷
关键词
Diabetes; Smartphone apps; mHealth; Behaviour change; Physical activity; Weight monitoring; Blood glucose monitoring; Medication adherence; Financial incentive;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Protocol update and baseline characteristics for the TRIal to slow the Progression of Diabetes (TRIPOD) randomized controlled trial
    Bairavi, Joann
    Gardner, Daphne Su-Lyn
    Yeoh, Ester
    Tham, Kwang Wei
    Gandhi, Mihir
    Tan, Ngiap Chuan
    Lee, Phong Ching
    Lim, Robyn Su May
    Adamjee, Thofique
    Cheung, Yin Bun
    Bee, Yong Mong
    Finkelstein, Eric Andrew
    TRIALS, 2023, 24 (01)
  • [2] TRIal to slow the Progression Of Diabetes (TRIPOD): study protocol for a randomized controlled trial using wireless technology and incentives
    Robyn Su May Lim
    Daphne Su Lyn Gardner
    Yong Mong Bee
    Yin Bun Cheung
    Joann Bairavi
    Mihir Gandhi
    Su-Yen Goh
    Emily Tse Lin Ho
    Xinyi Lin
    Ngiap Chuan Tan
    Tunn Lin Tay
    Eric Andrew Finkelstein
    Trials, 20
  • [3] TRIal to slow the Progression Of Diabetes (TRIPOD): study protocol for a randomized controlled trial using wireless technology and incentives
    Lim, Robyn Su May
    Gardner, Daphne Su Lyn
    Bee, Yong Mong
    Cheung, Yin Bun
    Bairavi, Joann
    Gandhi, Mihir
    Goh, Su-Yen
    Ho, Emily Tse Lin
    Lin, Xinyi
    Tan, Ngiap Chuan
    Tay, Tunn Lin
    Finkelstein, Eric Andrew
    TRIALS, 2019, 20 (01)
  • [4] Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial
    Diamantidis, Clarissa J.
    Bosworth, Hayden B.
    Oakes, Megan M.
    Davenport, Clemontina A.
    Pendergast, Jane F.
    Patel, Sejal
    Moaddeb, Jivan
    Barnhart, Huiman X.
    Merrill, Peter D.
    Baloch, Khaula
    Crowley, Matthew J.
    Patel, Uptal D.
    CONTEMPORARY CLINICAL TRIALS, 2018, 69 : 28 - 39
  • [5] Baseline characteristics in the myopia progression study, a clinical trial of bifocals to slow myopia progression
    Fulk, GW
    Cyert, LA
    Parker, DE
    OPTOMETRY AND VISION SCIENCE, 1998, 75 (07) : 485 - 492
  • [6] A multicomponent integrative intervention to slow down the progression of mild cognitive impairment: A protocol for a randomized controlled trial
    Lyu, Qiyuan
    Cheung, Daphne S. K.
    Lai, Huilan
    Wang, Xiaomeng
    Qiu, Jing
    Huang, Yuanqiu
    Zeng, Yingchun
    RESEARCH IN NURSING & HEALTH, 2020, 43 (04) : 307 - 316
  • [7] EVALUATING THE EFFICACY OF MYSUGR IN A RANDOMIZED CONTROLLED TRIAL: BASELINE CHARACTERISTICS
    Ehrmann, D.
    Kulzer, B.
    Silbermann, S.
    Kober, J.
    Finke-Grone, K.
    Roos, T.
    Vesper, I.
    Schafer, V.
    Hermanns, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A66 - A66
  • [8] THE DIABETES TELEMONITORING OF PATIENTS IN INSULIN THERAPY (DIAMONT) TRIAL: PROTOCOL FOR A RANDOMIZED CONTROLLED TRIAL
    Hangaard, S.
    Kronborg, T.
    Hejlesen, O.
    Aradottir, T.
    Kaas, A.
    Bengtsson, H.
    Jensen, M. H.
    Vestergaard, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A135 - A135
  • [9] Comparison of baseline patient characteristics of the CONVINCE randomized controlled trial with existing trial and registry populations
    Yuen, Tom
    Pham, Ngoc
    Ho, Kakiu
    Braun, Jennifer
    Stauss-Grabo, Manuela
    Strippoli, Giovanni
    Cromm, Krister
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1380 - I1381
  • [10] Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial
    Nathan S. Fishbein
    Ana-Maria Vranceanu
    Ryan A. Mace
    Journal of Neuro-Oncology, 2022, 159 : 637 - 646